Abiraterone 154229-19-3

Min.Order / FOB Price:Get Latest Price

1 Kilogram	FOB Price:USD 4.8000 -5.0000

1 Kilogram

FOB Price:USD 4.8000 -5.0000

Min.Order :1 Kilogram
Purity: 99%
Payment Terms : L/C,D/A,D/P,T/T,Other

Keywords

Abiraterone manufacturer 98-92-0 Abiraterone seller

Quick Details

Appearance:White powder
Application:Blood lipid regulation, anti - atherosclerosis drugs
PackAge:25KG/DRUM
ProductionCapacity:1000|Kilogram|Year
Storage:Store at +4°C
Transportation:General cargo transport

Superiority:

We are concentrating on APIs and pharmaceutical intermediates.

With in depth knowledge and understanding in this industry, we are indulged in supplying a wide assortments of Abiraterone from Wuhan, Hubei, China.

It is made obtainable from us at the most reasonable rate.

Details:

Company Profile:

Company name: Hanways ChemPharm Co., Ltd.

Year Establishment: 2009

Location: 18-1-802, Green Garden, Jianghan District, Wuhan 430023, China

Main product:
- API: Antiobesity; Oncology; Antiviral; Cardiovascular; Antibiotics; Antidiabetics and others
- Peptides
- Hormones
- Intermediates

Product Name: Abiraterone

CAS: 154229-19-3

MF: C24H31NO

MW: 349.51

EINECS: 810-941-6

Appearance: White powder

Package:1kg/2kg/5kg aluminum foil/tin, 25kg/drum

Brand: Hanwayschem

Abiraterone is a new type of hormone therapy. It is also called abiraterone acetate, CB7630 or Zytiga. It is used to treat prostate cancer that has spread to other parts of the body. It may help some men to live longer. It can also help control symptoms. Clinical trials are also using abiraterone for earlier stages of prostate cancer and advanced breast cancer. Abiraterone is associated with a not uncommon rate of serum enzyme elevation during therapy, but has not been clearly linked to cases of clinically apparent liver injury with jaundice.

On April 28, 2011, the U.S. Food and Drug Administration approved abiraterone acetate (Zytiga Tablets, Centocor Ortho Biotech, Inc.) for use in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) who have received prior chemotherapy containing docetaxel.

Abiraterone is a steroidal compound with antiandrogen activity. it is a Cytochrome P450 17A1 Inhibitor. The mechanism of action of abiraterone is as a Cytochrome P450 17A1 Inhibitor, and Cytochrome P450 2D6 Inhibitor, and Cytochrome P450 2C8 Inhibitor that catalyzes the 17alpha-hydroxylation of steroid intermediates involved in testosterone synthesis. Administration of this agent may suppress testosterone production by both the testes and the adrenals to castrate-range levels.

Our Factory:

View All

Visit Store